Free Trial
→ Uncle Sam now owns 9.9% of Intel (From Porter & Company) (Ad)tc pixel Free OACC Stock Alerts

Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors

Oaktree Acquisition Corp. III Life Sciences logo
$10.65 0.00 (0.00%)
As of 06/8/2026 03:45 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

OACC vs. ESRT, TIGR, RPC, IPXX, and ABX

Should you buy Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? MarketBeat compares Oaktree Acquisition Corp. III Life Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oaktree Acquisition Corp. III Life Sciences include Empire State Realty Trust (ESRT), UP Fintech (TIGR), Ridgepost Capital (RPC), Inflection Point Acquisition Corp. II (IPXX), and Abacus Global Management (ABX). These companies are all part of the "trading" industry.

How does Oaktree Acquisition Corp. III Life Sciences compare to Empire State Realty Trust?

Empire State Realty Trust (NYSE:ESRT) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Empire State Realty Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empire State Realty Trust$768.27M1.28$47.60M$0.2621.93
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

Empire State Realty Trust has a net margin of 5.09% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Empire State Realty Trust's return on equity of 2.19% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Empire State Realty Trust5.09% 2.19% 0.93%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

In the previous week, Empire State Realty Trust had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Empire State Realty Trust and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Empire State Realty Trust's score of 0.44 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Empire State Realty Trust Neutral
Oaktree Acquisition Corp. III Life Sciences Very Positive

67.1% of Empire State Realty Trust shares are owned by institutional investors. 15.2% of Empire State Realty Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Empire State Realty Trust has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

Empire State Realty Trust currently has a consensus price target of $5.92, suggesting a potential upside of 3.78%. Given Empire State Realty Trust's stronger consensus rating and higher probable upside, equities analysts clearly believe Empire State Realty Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Empire State Realty Trust
2 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.33
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Empire State Realty Trust beats Oaktree Acquisition Corp. III Life Sciences on 10 of the 11 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to UP Fintech?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and UP Fintech (NASDAQ:TIGR) are both small-cap trading companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

In the previous week, UP Fintech had 8 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 9 mentions for UP Fintech and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat UP Fintech's score of -0.12 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
UP Fintech Neutral

UP Fintech has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
UP Fintech$612.07M1.46$170.90M$0.607.87

UP Fintech has a consensus price target of $9.23, suggesting a potential upside of 95.60%. Given UP Fintech's stronger consensus rating and higher probable upside, analysts plainly believe UP Fintech is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
UP Fintech
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, indicating that its share price is 101% less volatile than the broader market. Comparatively, UP Fintech has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

UP Fintech has a net margin of 17.64% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. UP Fintech's return on equity of 13.90% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
UP Fintech 17.64%13.90%1.30%

9.0% of UP Fintech shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

UP Fintech beats Oaktree Acquisition Corp. III Life Sciences on 10 of the 11 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Ridgepost Capital?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Ridgepost Capital (NYSE:RPC) are both small-cap financial services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Ridgepost Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Ridgepost Capital$297.35M3.05$19.50M$0.2237.71

Ridgepost Capital has a net margin of 7.99% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Ridgepost Capital's return on equity of 24.58% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Ridgepost Capital 7.99%24.58%10.56%

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, meaning that its share price is 101% less volatile than the broader market. Comparatively, Ridgepost Capital has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Ridgepost Capital has a consensus price target of $12.00, suggesting a potential upside of 44.65%. Given Ridgepost Capital's stronger consensus rating and higher probable upside, analysts clearly believe Ridgepost Capital is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ridgepost Capital
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Ridgepost Capital had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Ridgepost Capital and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Ridgepost Capital's score of 0.00 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Ridgepost Capital Neutral

48.1% of Ridgepost Capital shares are held by institutional investors. 11.5% of Ridgepost Capital shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Ridgepost Capital beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Inflection Point Acquisition Corp. II?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Inflection Point Acquisition Corp. II (NASDAQ:IPXX) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inflection Point Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, suggesting that its stock price is 101% less volatile than the broader market. Comparatively, Inflection Point Acquisition Corp. II has a beta of 0.17, suggesting that its stock price is 83% less volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Inflection Point Acquisition Corp. II N/A N/A N/A

In the previous week, Oaktree Acquisition Corp. III Life Sciences and Oaktree Acquisition Corp. III Life Sciences both had 1 articles in the media. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Inflection Point Acquisition Corp. II's score of 0.00 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Inflection Point Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Inflection Point Acquisition Corp. IIN/AN/AN/AN/AN/A

Summary

Oaktree Acquisition Corp. III Life Sciences beats Inflection Point Acquisition Corp. II on 2 of the 3 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Abacus Global Management?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Abacus Global Management (NYSE:ABX) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Abacus Global Management has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Abacus Global Management$235.24M3.64$36.53M$0.3922.92

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, meaning that its share price is 101% less volatile than the broader market. Comparatively, Abacus Global Management has a beta of 0.09, meaning that its share price is 91% less volatile than the broader market.

Abacus Global Management has a net margin of 15.63% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Abacus Global Management's return on equity of 20.02% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Abacus Global Management 15.63%20.02%9.65%

In the previous week, Abacus Global Management had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Abacus Global Management and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Abacus Global Management's score of 1.00 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Abacus Global Management Positive

Abacus Global Management has a consensus target price of $10.00, indicating a potential upside of 11.88%. Given Abacus Global Management's stronger consensus rating and higher probable upside, analysts clearly believe Abacus Global Management is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Abacus Global Management
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Abacus Global Management beats Oaktree Acquisition Corp. III Life Sciences on 8 of the 9 factors compared between the two stocks.

Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OACC vs. The Competition

Export
MetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$261.81M$322.72M$5.71B$12.06B
Dividend YieldN/AN/A5.28%5.55%
P/E RatioN/A2.2616.3423.76
Price / SalesN/A191.941,104.24105.22
Price / CashN/A136.8291.9056.09
Price / BookN/A348.516.506.72
Net IncomeN/A-$66.73M$1.13B$337.35M
7 Day Performance-0.14%0.05%0.13%-1.21%
1 Month Performance-0.84%3.65%0.93%1.41%
1 Year Performance1.04%5.18%18.46%23.64%

Oaktree Acquisition Corp. III Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OACC
Oaktree Acquisition Corp. III Life Sciences
N/A$10.65
flat		N/A+1.2%$261.81MN/AN/AN/A
ESRT
Empire State Realty Trust
1.6297 of 5 stars		$5.74
+0.2%		$6.35
+10.6%		-32.4%$990.09M$768.27M22.09670
TIGR
UP Fintech
2.8148 of 5 stars		$5.14
flat		$11.83
+130.2%		-45.4%$975.06M$538.71M5.651,346
RPC
Ridgepost Capital
4.243 of 5 stars		$8.29
+0.1%		$12.00
+44.8%		N/A$907.04M$297.35M37.66180
IPXX
Inflection Point Acquisition Corp. II
N/A$28.01
-0.6%		N/A+92.3%$875.31MN/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OACC) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...
The Oxford Club | Sponsoredtc pixel
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...
Porter & Company | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
This IPO Could Make SpaceX Look Small (Read before June 16)
A red-hot AI startup just filed to go public - already valued at nearly $1 trillion. Wall Street veteran Marc ...
Chaikin Analytics | Sponsoredtc pixel